Small Molecules
3 February 2014
Pfizer Announces Positive Top-Line Results From PALOMA-1 Evaluating Palbociclib Plus Letrozole in Women with Advanced Breast Cancer1 February 2014
FDA Approves HETLIOZ™ (tasimelteon) for the Treatment of Non-24-Hour Sleep-Wake Disorder31 January 2014
AbbVie Completes Largest Phase III Program of an All-Oral, Interferon-Free Therapy for the Treatment of Hepatitis C Genotype 130 January 2014
Salix Announces Acceptance of NDA Filing For Budesonide Foam in Patients with Distal Ulcerative Colitis29 January 2014
Tokai Pharmaceuticals’ Reformulated Galeterone Demonstrates Robust PSA Reductions in Advanced Prostate Cancer Patients29 January 2014
Nymox Provides Update on NX-1207 Phase 3 BPH and Phase 2 Prostate Cancer Clinical Trial Activities27 January 2014
Immune Design Announces Treatment of First Patient in Phase 1 Clinical Trial of ID-G100, an Investigational Immuno-Oncology Agent25 January 2014
TherapeuticsMD Initiates Phase 3 Clinical Trial of Its Progesterone Candidate (TX 12-002-HR) for Treatment of Secondary Amenorrhea25 January 2014
Endocyte Provides Update on CHMP Review of Pending EU Conditional Marketing Authorization Applications for Vintafolide and Etarfolatide25 January 2014
Bayer’s Riociguat Recommended for Approval in the EU in Two Forms of Pulmonary HypertensionNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports